{"nct_id":"NCT03311659","title":"Evaluation of Immunogenicity, Safety and Reactogenicity of GSK Biologicals' Boostrix Vaccine Administered as a Booster Dose in Healthy Russian Subjects","status":"COMPLETED","status_verified_date":"2020-10","start_date":"2018-01-26","start_date_type":"ACTUAL","primary_completion_date":"2018-08-31","primary_completion_date_type":"ACTUAL","completion_date":"2018-08-31","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}